Current and Future Directions for PARP Inhibition

Megan Grudem, APRN, CNP, and Andrea Wahner Hendrickson, MD, reviewed the potential role of PARP inhibition in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Grudem, Megan, Hendrickson, Andrea Wahner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857320/
https://www.ncbi.nlm.nih.gov/pubmed/33598329
http://dx.doi.org/10.6004/jadpro.2020.11.3.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857320/
https://www.ncbi.nlm.nih.gov/pubmed/33598329
http://dx.doi.org/10.6004/jadpro.2020.11.3.16

Ejemplares similares